GMP biologic drug lot or batch release testing services addressing purity, concentration, consistency, identity and biosafety of drug substances or drug products

GMP lot or batch release testing services for biologic drug substances or drug products are important to ensure the quality control of proteins, monoclonal antibodies (mAbs) or biosimilars. A range of tests are required as part of release testing activities to address the purity, concentration, consistency, identity and biosafety of products.

Our scientists routinely develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Pharmacopeia monographs including USP and Eur. Ph. monographs and test methods.

Intertek's release tests are applied to biosimilars, protein therapeutics, monoclonal antibodies, oligonucleotides and other biotechnology products.  Bringing quality and safety to life, our Total Quality Assurance expertise delivers responsive quality control analysis for complex biologic products from our cGMP laboratories which are aligned to supporting both the development and manufacture of biotechnology products.

Biologics release testing services include:

  • Pharmacopeia Monograph Tests
  • Protein purity assay and related proteins (HPLC and Isoelectric Focusing (IEF))
  • Peptide mapping via LC-MS methods
  • Impurities with higher molecular masses (Size Exclusion Chromatography - High performance Liquid Chromatography (SEC-HPLC))
  • Species with differing charge isomers (IE-HPLC)
  • PAGE-gel electrophoresis
  • Protein concentration (A280, Bradford Assay, HPLC)
  • Amino acid analysis
  • Residual contaminant assays
  • Host cell protein (HCPs) determination
  • cGMP Cell-based Bioassays
  • Physicochemical properties including appearance, colour, clarity/opalescence pH, particulates, turbidity, extractable volume, osmolality and moisture 

Routine Biosimilar Batch Release Testing Services

Routine biosimilar batch release testing services are available for a range of biosimilar products including a wide range of monoclonal antibody biosimilars:

  • Epoetin α
  • Filgrastim,
  • Insulin
  • Interferons α, β, γ
  • Human Coagulation Factor VII, VIII
  • Somatropin
  • Trastuzumab
  • Interlukin-2

Need help or have a question?

Related Links

An artistic representation of a DNA molecule comprised of dots coloured in shades of white to turquoise against a dark background

3rd Annual Inhaled & Nasal Biologics/DNA Forum

26-27 September 2024 | Cambridge, UK 

Join us for a ground-breaking and insightful forum on inhaled and nasal biologics development: Two days of cutting-edge talks and networking opportunities with leaders in this complex area of inhaled medication and inhaled vaccine development.

Discover our services

  • In vitro Toxicology Screening Services to Help Minimise Liabilities and Inform Drug Development Strategies
    Learn more 
  • Drug Tolerance Assessment and Improvement in Cell Based NAb Assays Using Response Data Modeling
    Learn more
  • Bioanalysis and Toxicology Challenges with ADC: How are They Different and New?
    Hosted by the Bioanalysis Zone
    Learn More
  • Overcoming Challenges in the Development and Validation of Biologics and Small Molecules in Ocular Tissues
    Hosted by the Bioanalysis Zone
    Learn more
  • Impact of Recent Changes to FDA Immunogenicity Draft Guidance
    Hosted by the Bioanalysis Zone
    Learn more
  • Additional webinars

Intertek Pharmaceutical Services Manchester
P.O. Box 42
Hexagon Tower
Manchester, M9 8ZS
United Kingdom

For location use: M9 8GQ

Sample Submission Guidelines


Contact Intertek